![conference banner](/images/conference-banner.jpeg)
Abstract
Introduction: The Low-Profile Visualized Intraluminal Support (LVIS) devices are a new generation of self-expandable, high-porosity stents approved for the treatment of large to giant wide-necked intracranial aneurysms via stent-assisted coiling. Here we report the radiographic and clinical outcomes seen with LVIS, LVIS Jr. and LVIS Blue from a single institution over a fiveyear period.
Methods: Patients with intracranial aneurysms treated by LVIS, LVIS Jr. and LVIS Blue technology over a five-year period (2012 - 2017) at our institution were retrospectively reviewed.
Results: Seventy-four patients (55 females and 19 males; average age = 59.2) with 74 aneurysms underwent embolization of intracranial aneurysms using LVIS (N = 10), LVIS Jr. (N = 47) or LVIS Blue (N = 12) devices at our institution over the study period. The most common location of treated aneurysms was the anterior communicating artery (31%), followed by the basilar artery (19%), and the middle cerebral artery (13%). The mean neck and dome sizes were 3.9±1.5mm and 6.6±3.2mm, respectively. The median follow-up time was 6 months. At the last radiographic follow- up, 93.1% of patients had complete occlusion (RR-I or OKM-D). In 5 cases (7%), the LVIS stent failed to open, requiring balloon angioplasty (N = 3) or stent recapture and use of a non-LVIS branded device (N = 2). Five patients had post-embolization infarcts, and 1 patient had an intra-operative dome rupture.
Conclusion: LVIS brand of stents is a safe, effective, and technically feasible treatment strategy for wide-neck intracranial aneurysms, with high deployment success and aneurysm obliteration rates.
Keywords: Aneurysm, device, stroke, subarachnoid, endovascular, LVIS devices.
[http://dx.doi.org/10.1056/NEJMoa070972] [PMID: 17978290]
[http://dx.doi.org/10.1093/ons/opy367] [PMID: 30541056]
[http://dx.doi.org/10.3171/2016.2.JNS152059] [PMID: 27128583]
[http://dx.doi.org/10.1016/S0140-6736(05)67190-5] [PMID: 16139637]
[http://dx.doi.org/10.1016/S0140-6736(05)67214-5] [PMID: 16139655]
[http://dx.doi.org/10.1136/neurintsurg-2015-012090] [PMID: 26747876]
[http://dx.doi.org/10.1136/neurintsurg-2015-012070] [PMID: 26534868]
[http://dx.doi.org/10.1136/neurintsurg-2017-013074] [PMID: 28939583]
[http://dx.doi.org/10.1136/neurintsurg-2017-013608] [PMID: 29331948]
[http://dx.doi.org/10.1136/neurintsurg-2015-011937] [PMID: 26391016]
[http://dx.doi.org/10.1136/neurintsurg-2017-013375] [PMID: 29175829]
[http://dx.doi.org/10.3174/ajnr.A4489] [PMID: 26316566]
[http://dx.doi.org/10.1136/neurintsurg-2014-011258] [PMID: 24898735]
[http://dx.doi.org/10.1177/159101991001600204] [PMID: 20642887]
[http://dx.doi.org/10.5469/neuroint.2017.12.1.31] [PMID: 28316867]
[http://dx.doi.org/10.1136/neurintsurg-2014-011229] [PMID: 24827067]
[http://dx.doi.org/10.1080/01616412.2018.1457608] [PMID: 29683412]
[http://dx.doi.org/10.1177/1591019920952903] [PMID: 32830566]
[http://dx.doi.org/10.1016/j.clineuro.2020.106117] [PMID: 32745790]
[http://dx.doi.org/10.1136/neurintsurg-2014-011457] [PMID: 25352581]
[http://dx.doi.org/10.1007/s00234-013-1277-z] [PMID: 24057085]
![Wayfinder Image](/images/wayfinder.jpg)